We are live on ! Find out more
BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Est. Return 108.39%
This Fund
S&P 500
This Quarter Est. Return
+48.38%
1 Year Est. Return
+108.39%
3 Year Est. Return
+261.8%
5 Year Est. Return
+1,135.09%
10 Year Est. Return
–
AUM
$1.77B
AUM Growth
+$389M
Cap. Flow
-$37.2M
Cap. Flow %
-2.11%
Top 10 Hldgs %
60.65%
Holding
62
New
13
Increased
10
Reduced
5
Closed
11

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$53M
2
LABD icon
Direxion Daily S&P Biotech Bear 3X ETF
LABD
+$51.2M
3
SAGE
Sage Therapeutics
SAGE
+$43.1M
4
ANAB icon
AnaptysBio
ANAB
+$30.7M
5
IMMU
Immunomedics Inc
IMMU
+$26.5M

Top Sells

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$160M
2
AMRN
Amarin Corp
AMRN
+$53.1M
3
PTCT icon
PTC Therapeutics
PTCT
+$33.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$32.8M
5
SLDB icon
Solid Biosciences
SLDB
+$21.1M

Sector Composition

Rank Sector Weight
1 Healthcare 81.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLRB icon
51
Cellectar Biosciences
CLRB
$20.5M
$2.07M 0.12%
3,067
– –
AMRN
52
Amarin Corp
AMRN
$299M
– –
-175,000
Closed -$53.1M
ELDN icon
53
Eledon Pharmaceuticals
ELDN
$261M
– –
-18,021
Closed -$201K
MRSN
54
DELISTED
Mersana Therapeutics
MRSN
– –
-67,232
Closed -$2.66M
PRTA icon
55
Prothena Corp
PRTA
$425M
– –
-79,598
Closed -$624K
PTCT icon
56
PTC Therapeutics
PTCT
$5.64B
– –
-1,000,000
Closed -$33.8M
VYGR icon
57
Voyager Therapeutics
VYGR
$183M
– –
-500,000
Closed -$8.61M
WVE icon
58
Wave Life Sciences
WVE
$1.09B
– –
-1,000,000
Closed -$20.5M
TECX
59
Tectonic Therapeutic
TECX
$529M
– –
-50,000
Closed -$8.47M
IMMU
60
CALL
DELISTED
Immunomedics Inc
IMMU
– –
-600,000
Closed -$7.96M
ONCE
61
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-1,650,000
Closed -$160M
ZGNX
62
DELISTED
Zogenix, Inc.
ZGNX
– –
-300,000
Closed -$12M
1 2
3

Similar funds

FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
SEC
Seven Eight Capital New York $1.11B AUM 29.48% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Boxer Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Boxer Capital held 62 positions worth $1.77B, up 28% from $1.38B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Boxer Capital's Q4 2019 filing shows 13 new, 10 increased, 5 reduced and 11 closed positions. Its largest new stake was Seagen Inc. Common Stock: 500,000 shares worth $57.1M. The largest sale was Spark Therapeutics, Inc. Common Stock, an estimated $160M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 78% a quarter earlier.

  • Boxer Capital's largest Q4 2019 buy was Seagen Inc. Common Stock: 500,000 shares worth $57.1M.
  • Boxer Capital added most to Immunomedics Inc in Q4 2019, an estimated $26.5M increase.
  • Boxer Capital's biggest Q4 2019 reduction was Sarepta Therapeutics, cutting an estimated $32.8M.
  • Boxer Capital fully exited Spark Therapeutics, Inc. Common Stock in Q4 2019, selling an estimated $160M.
  • Boxer Capital's ten largest holdings make up 61% of its $1.77B portfolio in Q4 2019.
  • Boxer Capital opened 13 new positions and closed 11 in Q4 2019.
  • Boxer Capital's portfolio value rose 28% quarter-over-quarter to $1.77B.

Based on Boxer Capital's 13F filing for Q4 2019, filed 14 Feb 2020.